ReferIndia News Share India Securities Limited Receives CRISIL A1+ Rating for ₹250 Crore Commercial Papers

ReferIndia News

Dr. Aditya Manke

Dr. Aditya Manke — Expert Robotic & Laparoscopic Cancer Surgeon. Precise care, faster recovery.

Contact Now
News Image

Share India Securities Limited Receives CRISIL A1+ Rating for ₹250 Crore Commercial Papers

Published on: Jan. 14, 2026, 1:33 p.m. | Source: scanx.trade

Share India Securities Limited received CRISIL A1+ rating for ₹250 crore Commercial Papers program on January 13, 2026. The highest short-term rating grade reflects strong credit quality and enhances the company's funding capabilities. The rating was disclosed to BSE and NSE on January 14, 2026, under SEBI regulatory requirements, strengthening the company's position in capital markets.

Checkout more news
Ad Banner

Planning a trip to Singapore?

Let's make it a seamless journey, bhai — full of fun, food, and unforgettable vibes! 🌟✈️

Contact Now
ReferIndia News contact